Results 61 to 70 of about 3,797 (199)
Erectile dysfunction (ED) is a common sexual disorder worldwide significantly affects men’s quality of life. However, there remains a lack of comprehensive bibliometric analysis of ED treatment. This study aims to utilize bibliometric methods to assess the research progress in ED treatment and identify the research hot spots and emerging trends in this
Kefan Li +13 more
wiley +1 more source
Phosphodiesterase‐5 Inhibition and Alzheimer's Disease Risk: A Mendelian Randomisation Study
Preclinical studies suggest PDE5 inhibitors may improve cognition, but observational evidence on Alzheimer's disease (AD) risk is mixed. We performed a cis‐Mendelian randomisation analysis across four AD genome‐wide association studies (GWAS) datasets and a sex‐stratified analysis using UK Biobank data.
Marta Alcalde‐Herraiz +9 more
wiley +1 more source
PURPOSE: Acute vasodilator testing is recommended in patients with pulmonary arterial hypertension to identify individuals who may benefit from long-term treatment with oral calcium channel blockers.
Wikström, Gerhard +13 more
core +1 more source
The Concise Guide to PHARMACOLOGY 2025/26: Enzymes
The Concise Guide to Pharmacology 2025/26 marks the seventh edition in this series of biennial publications in the British Journal of Pharmacology. Presented in landscape format, the guide provides a comparative overview of the pharmacology of drug target families. The concise nature of the Concise Guide refers to the style of presentation, being clear,
Stephen P. H. Alexander +31 more
wiley +1 more source
ABSTRACT Pulmonary Arterial Hypertension (PAH) is a rare, chronic and progressive disease affecting the heart and lungs. Endothelin receptor antagonist (ERA) + phosphodiesterase type 5 inhibitor (PDE5i) treatment is recommended for all PAH patients. The two approved PDE5is are tadalafil and sildenafil.
Rajan Saggar +9 more
wiley +1 more source
Multiple inflammatory, infectious and autoimmune dermato‐venereological conditions are associated with erectile dysfunction (ED) due to underlying intricate vasculogenic, neurogenic, endocrine and psychogenic mechanisms. It is recommended that practitioners screen dermatology patients for ED and associated comorbidities, provide personalized lifestyle ...
Andrei Tanasov, George‐Sorin Tiplica
wiley +1 more source
Incremental cost-effectiveness of various monthly doses of vardenafil
ObjectiveTo compare the cost-effectiveness of four, six, and eight doses per month of vardenafil in the context of pharmacy benefit decision making.MethodsA Markov model was used to estimate the incremental cost-effectiveness of zero, four, six, or eight
Good, Chester B. +7 more
core +1 more source
Multi‐cohort snRNA‐seq analysis identified 20 key transcriptional regulators in Alzheimer's disease (AD). Lasmiditan was the top drug identified for repurposing as it showed strong binding stability with ETV6 and favourable blood–brain barrier permeability.
Martin Nwadiugwu +5 more
wiley +1 more source
Efficacy and Safety of Vardenafil in Renal Transplant Recipients With Erectile Dysfunction
PubMedID: 16797309Erectile dysfunction (ED) profoundly affects the quality of life. The prevalence of ED in renal transplant recipients is reported by high as 50% to 60%.
Balal M. +4 more
core +1 more source
ABSTRACT Background Vision loss following a facial esthetic procedure with soft‐tissue fillers is an event for which there is only a short treatment window to restore blood flow before irreversible ischemic damage occurs. Objective To provide a current standardized treatment approach for the management of retinal artery occlusion after intra‐arterial ...
Sheila Barbarino +2 more
wiley +1 more source

